Facts and fictions about polymorphism.
暂无分享,去创建一个
[1] G. Day,et al. Static and lattice vibrational energy differences between polymorphs , 2015 .
[2] Joel Bernstein,et al. “Predicting” Crystal Forms of Pharmaceuticals Using Hydrogen Bond Propensities: Two Test Cases , 2014 .
[3] R. Tan,et al. Polymorphism in cocrystals: a review and assessment of its significance , 2014 .
[4] J. McMahon,et al. Contrasting Polymorphism of Related Small Molecule Drugs Correlated and Guided by the Computed Crystal Energy Landscape , 2014 .
[5] D. Presti,et al. Oxalyl dihydrazide polymorphism: a periodic dispersion-corrected DFT and MP2 investigation , 2014 .
[6] S. Price. Why don't we find more polymorphs? , 2013, Acta crystallographica Section B, Structural science, crystal engineering and materials.
[7] G. Stephenson,et al. Crystal Structure Prediction of a Flexible Molecule of Pharmaceutical Interest with Unusual Polymorphic Behavior , 2013 .
[8] A. Tkatchenko,et al. Many-body dispersion interactions in molecular crystal polymorphism. , 2012, Angewandte Chemie.
[9] C. Adjiman,et al. The polymorphs of ROY: application of a systematic crystal structure prediction technique. , 2012, Acta crystallographica. Section B, Structural science.
[10] G. Beran,et al. Crystal Polymorphism in Oxalyl Dihydrazide: Is Empirical DFT-D Accurate Enough? , 2012, Journal of chemical theory and computation.
[11] S. Price,et al. Is the Fenamate Group a Polymorphophore? Contrasting the Crystal Energy Landscapes of Fenamic and Tolfenamic Acids , 2012 .
[12] G. Stephenson,et al. Symmetry Breaking: Polymorphic Form Selection by Enantiomers of the Melatonin Agonist and Its Missing Polymorph , 2012 .
[13] A. Tkatchenko,et al. Accurate and efficient method for many-body van der Waals interactions. , 2012, Physical review letters.
[14] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[15] Alfred Y Lee,et al. Crystal polymorphism in chemical process development. , 2011, Annual review of chemical and biomolecular engineering.
[16] F. Leusen,et al. Molecule VI, a benchmark crystal-structure-prediction sulfonimide: are its polymorphs predictable? , 2011, Angewandte Chemie.
[17] A. Bond,et al. Single crystals of aspirin form II: crystallisation and stability , 2011 .
[18] Marcus A. Neumann,et al. Validation of experimental molecular crystal structures with dispersion-corrected density functional theory calculations , 2010, Acta crystallographica. Section B, Structural science.
[19] Frank H. Allen,et al. Truly prospective prediction: inter- and intramolecular hydrogen bonding , 2010 .
[20] Peter T. A. Galek,et al. Universal prediction of intramolecular hydrogen bonds in organic crystals. , 2010, Acta crystallographica. Section B, Structural science.
[21] Peter T. A. Galek,et al. Knowledge-based H-bond prediction to aid experimental polymorph screening , 2009 .
[22] M. Neumann,et al. Can crystal structure prediction guide experimentalists to a new polymorph of paracetamol , 2009 .
[23] A. Bond. Polymorphism in molecular crystals , 2009 .
[24] J. Senker,et al. Wöhler and Liebig Revisited: 176 Years of Polymorphism in Benzamide - and the Story Still Continues!† , 2009 .
[25] Peter T. A. Galek,et al. Persistent hydrogen bonding in polymorphic crystal structures. , 2009, Acta crystallographica. Section B, Structural science.
[26] S. Price,et al. Computational prediction of organic crystal structures and polymorphism , 2008 .
[27] Sarah L Price,et al. Modeling the interplay of inter- and intramolecular hydrogen bonding in conformational polymorphs. , 2008, The Journal of chemical physics.
[28] Ashwini Nangia,et al. Conformational polymorphism in organic crystals. , 2008, Accounts of chemical research.
[29] Jonathan M Goodman,et al. Polymorph control: past, present and future. , 2008, Drug discovery today.
[30] J. Boeyens,et al. Models, mysteries, and magic of molecules , 2008 .
[31] Peter T. A. Galek,et al. Knowledge-based model of hydrogen-bonding propensity in organic crystals. , 2007, Acta crystallographica. Section B, Structural science.
[32] J. Senker,et al. Polymorphism in benzamide: solving a 175-year-old riddle. , 2007, Angewandte Chemie.
[33] M. Spackman,et al. Solvent inclusion in the structural voids of form II carbamazepine: single-crystal X-ray diffraction, NMR spectroscopy and Hirshfeld surface analysis , 2007 .
[34] G. P. Stahly. Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals , 2007 .
[35] G. Day,et al. Solvent inclusion in form II carbamazepine. , 2007, Chemical communications.
[36] J. Steed,et al. Comment on “On the presence of multiple molecules in the crystal asymmetric unit (Z′ > 1)” by Gautam R. Desiraju, CrystEngComm, 2007, 9, 91 , 2007 .
[37] G. Desiraju,et al. On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains. , 2007, Angewandte Chemie.
[38] Gautam R. Desiraju,et al. On the presence of multiple molecules in the crystal asymmetric unit ( Z ′ > 1) , 2007 .
[39] G. Day,et al. Importance of Molecular Shape for the Overall Stability of Hydrogen Bond Motifs in the Crystal Structures of Various Carbamazepine-Type Drug Molecules , 2007 .
[40] Stefan Grimme,et al. Semiempirical GGA‐type density functional constructed with a long‐range dispersion correction , 2006, J. Comput. Chem..
[41] J. Bernstein,et al. Serendipity and four polymorphic structures of benzidine, C12H12N2. , 2006, Journal of the American Chemical Society.
[42] G. Day,et al. Amide Pyramidalization in Carbamazepine: A Flexibility Problem in Crystal Structure Prediction? , 2006 .
[43] G. Desiraju,et al. Dimorphs of 4′-amino-4-hydroxy-2′-methylbiphenyl: Assessment of likelihood of polymorphism in flexible molecules , 2006 .
[44] K. Harris,et al. Abundant polymorphism in a system with multiple hydrogen-bonding opportunities: oxalyl dihydrazide. , 2006, Journal of the American Chemical Society.
[45] J. Steed,et al. Unusual variations in the incidence of Z' > 1 in oxo-anion structures. , 2006, Chemical communications.
[46] L. Reddy,et al. Carboxamide-pyridine N-oxide heterosynthon for crystal engineering and pharmaceutical cocrystals. , 2006, Chemical communications.
[47] Peddy Vishweshwar,et al. Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.
[48] Rolf Hilfiker,et al. POLYMORPHISM , 1945 .
[49] Peddy Vishweshwar,et al. The predictably elusive form II of aspirin. , 2005, Journal of the American Chemical Society.
[50] K. Shankland,et al. Polymorphism in benzamide. , 2005, Angewandte Chemie.
[51] J. McMahon,et al. Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients. , 2005, Chemical communications.
[52] Abu T M Serajuddin,et al. Trends in solubility of polymorphs. , 2005, Journal of pharmaceutical sciences.
[53] A. Matzger,et al. Crystalline polymorph selection and discovery with polymer heteronuclei. , 2005, Journal of the American Chemical Society.
[54] James A. Chisholm,et al. COMPACK: a program for identifying crystal structure similarity using distances , 2005 .
[55] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[56] William Jones,et al. Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.
[57] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[58] Michael J. Zaworotko,et al. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2003, Chemical communications.
[59] J. Bauer,et al. Ritonavir: An Extraordinary Example of Conformational Polymorphism , 2001, Pharmaceutical Research.
[60] J. Steed. Should solid-state molecular packing have to obey the rules of crystallographic symmetry? , 2003 .
[61] M. Spackman,et al. Fingerprinting intermolecular interactions in molecular crystals , 2002 .
[62] Joel Bernstein,et al. Polymorphism in Molecular Crystals , 2002 .
[63] Robin Taylor,et al. New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.
[64] D. Grant,et al. Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data. , 2001, Journal of pharmaceutical sciences.
[65] S. Chemburkar,et al. Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development , 2000 .
[66] C. Görbitz,et al. On the inclusion of solvent molecules in the crystal structures of organic compounds , 2000, Acta crystallographica. Section B, Structural science.
[67] G. Kresse,et al. From ultrasoft pseudopotentials to the projector augmented-wave method , 1999 .
[68] Michael J. Zaworotko,et al. Crystal engineering : the design and application of functional solids , 1999 .
[69] G. Desiraju,et al. Design of organic solids , 1998 .
[70] Christer B. Aakeröy,et al. Crystal engineering : Strategies and architectures , 1997 .
[71] Burke,et al. Generalized Gradient Approximation Made Simple. , 1996, Physical review letters.
[72] Kresse,et al. Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set. , 1996, Physical review. B, Condensed matter.
[73] G. Kresse,et al. Efficiency of ab-initio total energy calculations for metals and semiconductors using a plane-wave basis set , 1996 .
[74] A. Gavezzotti,et al. Polymorphic Forms of Organic Crystals at Room Conditions: Thermodynamic and Structural Implications , 1995 .
[75] Blöchl,et al. Projector augmented-wave method. , 1994, Physical review. B, Condensed matter.
[76] Hafner,et al. Ab initio molecular-dynamics simulation of the liquid-metal-amorphous-semiconductor transition in germanium. , 1994, Physical review. B, Condensed matter.
[77] Hafner,et al. Ab initio molecular dynamics for liquid metals. , 1995, Physical review. B, Condensed matter.
[78] K. Seddon,et al. The hydrogen bond and crystal engineering , 1994 .
[79] Jack D. Dunitz,et al. Phase transitions in molecular crystals from a chemical viewpoint , 1991 .
[80] G. Desiraju,et al. Crystal Engineering: A Textbook , 1989 .
[81] A. P. Lötter,et al. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. , 1987, Journal of pharmaceutical sciences.
[82] A. Burger,et al. On the polymorphism of pharmaceuticals and other molecular crystals. I , 1979 .
[83] A. Burger,et al. On the polymorphism of pharmaceuticals and other molecular crystals. II , 1979 .
[84] A. Hagler,et al. Conformational polymorphism. The influence of crystal structure on molecular conformation , 1978 .
[85] H. Monkhorst,et al. SPECIAL POINTS FOR BRILLOUIN-ZONE INTEGRATIONS , 1976 .
[86] W. Mccrone,et al. Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.
[87] J. White,et al. The crystal and molecular structure of benzamide , 1959 .
[88] O. Lehmann. Ueber physikalische Isomerie , 1877 .